MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The efficacy of Botulinum toxin A in reducing muscle spasticity by different volumes of dilution

    R. Marvulli, G. Ianieri, G. Mintrone, A. Zonno, L. Rizzo, G. Farì, M. Ranieri, M. Megna (Bari, Italy)

    Objective: Spasticity is a speed-dependent increase in muscle tone associated with stiffness, enhanced osteotendinous reflexes, paresis, loss of fine motor control, and increased fatigue. The…
  • 2022 International Congress

    GAIT ANALYSIS IN PARKINSONIAN SUBJECTS WITH PISA SYNDROME SUBJECTED TO TREATMENT WITH BOTULINUM TOXIN

    R. Marvulli, G. Ianieri, A. Zonno, G. Mintrone, G. Farì, L. Rizzo, M. Ranieri, M. Megna (Bari, Italy)

    Objective: The aim was to evaluate the activation characteristics of the muscles involved in patients with Pisa Syndrome with surface electromyography (EMG) during walking after…
  • 2022 International Congress

    Action verb use in PD: A challenge to the embodied cognition hypothesis?

    E. Nascimento Andrade, C. Manxhari, K. Smith (Worcester, USA)

    Objective: To characterize action verb production in Parkinson's disease (PD) during a picture description task, and evaluate associations with motor and cognitive function. Background: The…
  • 2022 International Congress

    Alien hand syndrome in ischemic stroke: a case-report

    K. Manysheva (Makhachkala, Russian Federation)

    Objective: Alien hand syndrome (AHS) is a rare movement disorder that inspires fear to patients and confuses doctors. So we describe a rare case-report. Background:…
  • 2022 International Congress

    A randomized controlled trial comparing the efficacy and safety of pyridostigmine versus midodrine for the treatment of orthostatic hypotension in Parkinson’s disease patients

    C. Limwatthana (Bangkok, Thailand)

    Objective: To assess the long-term efficacy and safety of pyridostigmine and midodrine in the treatment of OH in PD. Background: In  Parkinson's  disease  (PD),  orthostatic…
  • 2022 International Congress

    Blaming neuromelanin for Parkinson’s disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in non-human primates

    J. Lanciego, J. Chocarro, A. Fajardo-Serrano, A. Vazquez, AI. Rodriguez-Perez, J. Labandeira-Garcia, M. Vila, A. Rico (Pamplona, Spain)

    Objective: Development and characterization of a novel non-human primate model of Parkinson’s disease based on the AAV-mediated forced expression of human tyrosinase Background: Although neuromelanin…
  • 2022 International Congress

    Use of apomorphine infusion pump in the elderly population : a 5 years follw up study on efficacy, safety and tolerability in a cohort bases study

    C. Borrue- Fernandez, M. Mata, C. Jimeno, M. Almarcha (San Sebastian Reyes, Spain)

    Objective: Evaluate the efficacy, tolerability and safety of subcutaneous apomorphine infusion in elderly patients with advanced Parkinson's disease in a five years follow up cohort. Background: Continuous infusion by subcutaneous apomorphine pump has…
  • 2022 International Congress

    Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings

    A. Mena, A. Strafella (Toronto, Canada)

    Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…
  • 2022 International Congress

    Subcutaneous Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Results From a Randomized, Double-blind, Double-dummy Phase 3 Trial

    M. Soileau, M. Spindler, J. Aldred, K. Budur, N. Fisseha, V. Fung, A. Jeong, T. Kimber, K. Klos, I. Litvan, D. O’Neill, W. Robieson, D. Standaert, S. Talapala, E. Okeanis Vaou, H. Zheng, M. Facheris, R. Hauser (Georgetown, USA)

    Objective: To evaluate the efficacy and safety/tolerability of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (a soluble formulation of levodopa/carbidopa prodrugs) vs oral levodopa/carbidopa in…
  • 2022 International Congress

    Dopaminergic Denervation as Predictors of Axial Dysfunction in Parkinson’s Disease

    J. Li, N. Phielipp (Irvine, USA)

    Objective: We aimed to assess the usefulness of dopamine binding scores as predictors of walking and balance problems and freezing of gait (FoG) in PD.…
  • « Previous Page
  • 1
  • …
  • 502
  • 503
  • 504
  • 505
  • 506
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley